Abbas A K, Takaoki M, Greene M I
J Exp Med. 1982 Apr 1;155(4):1216-21. doi: 10.1084/jem.155.4.1216.
BALB/c mice immunized intravenously with syngeneic splenocytes, to which affinity-purified IgA produced by the MOPC 315 myeloma is covalently coupled, develop suppressor T cells (Ts1) that inhibit IgA secretion by MOPC 315 cells after 3-4 d of co-culture. Immunization with M315-coupled splenocytes subcutaneously, followed by administration of a soluble extract of Ts1 cells, leads to the generation of effector Ts that are also idiotype specific and inhibit myeloma function within 1 d. Moreover, effector Ts are Lyt-1-2+, whereas Ts1 are either Lyt-1+2+ or require Lyt-1+ and Lyt-2+ cells to mature into effector Ts in vitro. Such a protocol should be useful for analyzing the interactions that result in the maturation of Ts and in defining the mechanisms of action of Ts, whose effect can be measured on a homogeneous target population and that are specific for a well-characterized myeloma idiotype.
用与MOPC 315骨髓瘤产生的亲和纯化IgA共价偶联的同基因脾细胞静脉内免疫BALB/c小鼠,在共培养3 - 4天后会产生抑制性T细胞(Ts1),这些细胞可抑制MOPC 315细胞分泌IgA。皮下用M315偶联的脾细胞免疫,随后给予Ts1细胞的可溶性提取物,会导致效应性Ts的产生,这些效应性Ts也是独特型特异性的,并且在1天内就能抑制骨髓瘤功能。此外,效应性Ts是Lyt-1-2+,而Ts1要么是Lyt-1+2+,要么需要Lyt-1+和Lyt-2+细胞在体外成熟为效应性Ts。这样的方案对于分析导致Ts成熟的相互作用以及确定Ts的作用机制应该是有用的,Ts的作用可以在同质靶细胞群体上进行测量,并且对特征明确的骨髓瘤独特型具有特异性。